Request Your Free Trend Report Now:

"Inside the world of cell therapies"

Discover how next-gen cell therapies are revolutionizing oncology. From off-the-shelf solutions to enhanced immune cell engineering, explore the innovations shaping tomorrow's treatments.

While uptake has been limited, cell therapy’s impact in cancer care is growing, and biotech companies have continued to invest in ways to improve it, such as through “off-the-shelf” options or by using different types of immune cells. Explore the current market for cancer cell therapies and what biotechs are working on next.

Included in this Trendline:

• Sana to lay off staff, deepen autoimmune focus in latest retrenchment
• Candid sets out to prove bispecifics can top CAR-T in autoimmune disease
• Lyell, in search of a turnaround, to buy cell therapy startup ImmPact

Offered Free by: BioPharma Dive and BRANY
See All Resources from: BioPharma Dive and BRANY